Theravance Biopharma TBPH Q2 2025 earnings
Reported August 12, 2025 · After market close
Revenue$26.2MBeat by $7.5M
EPS-$0.08Beat by $0.06
Revenue estimate$18.7M
EPS estimate-$0.14
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$22.5M
EPS estimate$0.07
Financials
Q2 2025Valuation & ratios
Segments
By segment
Versus estimates
Revenue
Diluted EPS
Ask the moment Theravance Biopharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Theravance Biopharma report Q2 2025 earnings?
- Theravance Biopharma (TBPH) reported Q2 2025 earnings on August 12, 2025 after market close.
- What were Theravance Biopharma's Q2 2025 revenue and EPS?
- Theravance Biopharma reported revenue of $26.2M and eps of $-0.08 for Q2 2025.
- Did Theravance Biopharma beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $18.7M by $7.5M. EPS beat the consensus estimate of $-0.14 by $0.06.
- How did Theravance Biopharma's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 83.7% from $14.3M a year earlier and eps grew 38.5% from $-0.13.
- Where can I find Theravance Biopharma's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-011408) directly on SEC EDGAR. The filing index links above go to sec.gov.